In what ways can cannabinoids serve as adjunct therapies for chronic disease management?
In what ways can cannabinoids serve as adjunct therapies for chronic disease management? Cannabinoids can serve as adjunct therapies for chronic disease management by providing symptom relief and improving the overall quality of life for patients. In conditions such as chronic pain, multiple sclerosis, and inflammatory bowel disease, cannabinoids can help alleviate symptoms such as pain, inflammation, and nausea. Additionally, cannabinoids may enhance the effectiveness of conventional treatments by providing complementary mechanisms of action, potentially leading to improved patient outcomes. Their role in reducing side effects from traditional medications, such as opioids or chemotherapy agents, further supports their use in chronic disease management. As research continues to advance, cannabinoids may become integral components of comprehensive care strategies for various chronic conditions (Krebs et al., 2021).